Literature DB >> 8591829

Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control.

L Cominacini1, A Fratta Pasini, U Garbin, A Davoli, A De Santis, M Campagnola, A Rigoni, M G Zenti, P Moghetti, V Lo Cascio.   

Abstract

The adhesion of leucocytes to the endothelium, an early step in atherogenesis, is mediated by cell adhesion molecules. In this study we evaluated the concentration of soluble adhesion molecules in patients with insulin-dependent (IDDM) and non-insulin-dependent diabetes mellitus (NIDDM) and studied its relation to glycaemic control. Soluble adhesion molecules E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular adhesion molecule-1 (VCAM-1) were measured in 31 diabetic patients (18 with IDDM and 13 with NIDDM), 20 hyperlipoproteinaemic patients (10 with type IIa and 10 with type IIb) and 20 healthy subjects. Increased E-selectin concentrations were found in the patients with IDDM and NIDDM and in the hyperlipoproteinaemic patients when compared to the control subjects (p < 0.01 for all the groups). ICAM-1 was found to be elevated only in the patients with NIDDM (p < 0.01). No significant differences in VCAM-1 concentration were found in the different groups of subjects. The concentration of plasma E-selectin was positively correlated with the glycated haemoglobin (r = 0.54, p < 0.01) in patients with IDDM and NIDDM. In the same patients E-selectin was not related to the concentrations of plasma lipids in spite of the fact that it was found to be elevated in hyperlipoproteinaemic subjects. The results though preliminary suggest that in diabetic patients the concentration of soluble adhesion molecules and especially of E-selectin may be related to metabolic control.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8591829     DOI: 10.1007/bf00402185

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  10 in total

Review 1.  Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance.

Authors:  A J Gearing; I Hemingway; R Pigott; J Hughes; A J Rees; S J Cashman
Journal:  Ann N Y Acad Sci       Date:  1992-12-04       Impact factor: 5.691

2.  Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells.

Authors:  R Pigott; L P Dillon; I H Hemingway; A J Gearing
Journal:  Biochem Biophys Res Commun       Date:  1992-09-16       Impact factor: 3.575

3.  Increased levels of the soluble adhesion molecule E-selectin in essential hypertension.

Authors:  A D Blann; W Tse; S J Maxwell; M A Waite
Journal:  J Hypertens       Date:  1994-08       Impact factor: 4.844

Review 4.  Circulating adhesion molecules in disease.

Authors:  A J Gearing; W Newman
Journal:  Immunol Today       Date:  1993-10

Review 5.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

6.  Evaluation of a mini-column chromatographic procedure for the measurement of hemoglobin A1c.

Authors:  P K Jaynes; M C Willis; P P Chou
Journal:  Clin Biochem       Date:  1985-02       Impact factor: 3.281

Review 7.  Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

Authors:  M Brownlee; A Cerami; H Vlassara
Journal:  N Engl J Med       Date:  1988-05-19       Impact factor: 91.245

8.  An NF kappa B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription.

Authors:  J Whelan; P Ghersa; R Hooft van Huijsduijnen; J Gray; G Chandra; F Talabot; J F DeLamarter
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

9.  Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation.

Authors:  A Faggiotto; R Ross; L Harker
Journal:  Arteriosclerosis       Date:  1984 Jul-Aug

10.  Studies on the pathogenesis of atherosclerosis. I. Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats.

Authors:  I Joris; T Zand; J J Nunnari; F J Krolikowski; G Majno
Journal:  Am J Pathol       Date:  1983-12       Impact factor: 4.307

  10 in total
  19 in total

Review 1.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Soluble adhesion molecules in NIDDM: increased concentration, relation to glycometabolic control and possible pathophysiological significance.

Authors:  M Steiner; K M Reinhardt; A D Blann
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

3.  Elevated circulating adhesion molecules in NIDDM--potential mediators in diabetic macroangiopathy.

Authors:  P Fasching; W Waldhäusl; O F Wagner
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

4.  Increased levels of plasma ELAM-1, ICAM-1 and VCAM-1 in NIDDM: possible role of oxidized LDL.

Authors:  L Cominacini; U Garbin; A Fratta Pasini; V Lo Cascio
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

5.  Significance of chemokines and activated platelets in patients with diabetes.

Authors:  S Nomura; A Shouzu; S Omoto; M Nishikawa; S Fukuhara
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

6.  The markers of inflammation and endothelial dysfunction in correlation with glycated haemoglobin are present in type 2 diabetes mellitus patients but not in their relatives.

Authors:  José Manuel Gómez; Ramon Vila; Pablo Catalina; Juan Soler; Lina Badimón; Manel Sahún
Journal:  Glycoconj J       Date:  2008-03-18       Impact factor: 2.916

7.  Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: effect of intensive anti-inflammatory treatment.

Authors:  Will Foster; David Carruthers; Gregory Y H Lip; Andrew D Blann
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

8.  Effect of acarbose on platelet-derived microparticles, soluble selectins, and adiponectin in diabetic patients.

Authors:  Takayuki Shimazu; Norihito Inami; Daisuke Satoh; Takayuki Kajiura; Kohichi Yamada; Toshiji Iwasaka; Shosaku Nomura
Journal:  J Thromb Thrombolysis       Date:  2009-01-10       Impact factor: 2.300

9.  Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications.

Authors:  Sridevi Devaraj; Anthony T Cheung; Ishwarlal Jialal; Steven C Griffen; Danh Nguyen; Nicole Glaser; Thomas Aoki
Journal:  Diabetes       Date:  2007-08-08       Impact factor: 9.461

10.  Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches.

Authors:  Christos Kalofoutis; Christina Piperi; Anastasios Kalofoutis; Fred Harris; David Phoenix; Jaipaul Singh
Journal:  Exp Clin Cardiol       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.